Grantham, Mayo, Van Otterloo & Co (GMO)’s Gyrodyne GYRO Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio GYRO Stock Details GYRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-79,658	Closed	-$643K	–	554
2024 Q1	$643K	Sell	79,658 -39,590	-33%	-$349K	﹤0.01%	422
2023 Q4	$1.86M	Hold	119,248	–	–	0.01%	353
2023 Q3	$1.83M	Hold	119,248	–	–	0.01%	410
2023 Q2	$1.83M	Hold	119,248	–	–	0.01%	447
2023 Q1	$1.83M	Hold	119,248	–	–	0.01%	428
2022 Q4	$1.38M	Hold	119,248	–	–	0.01%	476
2022 Q3	$1.39M	Hold	119,248	–	–	0.01%	463
2022 Q2	$1.39M	Hold	119,248	–	–	0.01%	482
2022 Q1	$1.39M	Sell	119,248 -14,854	-11%	-$185K	0.01%	485
2021 Q4	$1.53M	Hold	134,102	–	–	0.01%	500
2021 Q3	$1.83M	Sell	134,102 -506	-0.4%	-$6.63K	0.01%	471
2021 Q2	$1.84M	Sell	134,608 -13,480	-9%	-$186K	0.01%	475
2021 Q1	$2.2M	Hold	148,088	–	–	0.01%	465
2020 Q4	$2.52M	Hold	148,088	–	–	0.02%	395
2020 Q3	$2.44M	Buy	148,088 +35,000	+31%	+$597K	0.02%	373
2020 Q2	$1.89M	Hold	113,088	–	–	0.01%	429
2020 Q1	$1.62M	Hold	113,088	–	–	0.01%	422
2019 Q4	$2.13M	Hold	113,088	–	–	0.01%	391
2019 Q3	$2.22M	Hold	113,088	–	–	0.02%	409
2019 Q2	$2.09M	Hold	113,088	–	–	0.01%	436
2019 Q1	$2.04M	Hold	113,088	–	–	0.01%	388
2018 Q4	$1.95M	Hold	113,088	–	–	0.02%	282
2018 Q3	$2.32M	Hold	113,088	–	–	0.02%	292
2018 Q2	$2.3M	Hold	113,088	–	–	0.02%	294
2018 Q1	$2.26M	Hold	113,088	–	–	0.01%	305
2017 Q4	$2.27M	Hold	113,088	–	–	0.01%	311
2017 Q3	$2.44M	Hold	113,088	–	–	0.01%	307
2017 Q2	$2.32M	Hold	113,088	–	–	0.01%	313
2017 Q1	$2.39M	Sell	113,088 -6,800	-6%	-$133K	0.01%	307
2016 Q4	$2.19M	Hold	119,888	–	–	0.01%	309
2016 Q3	$2.27M	Hold	119,888	–	–	0.01%	322
2016 Q2	$2.4M	Hold	119,888	–	–	0.01%	350
2016 Q1	$3.23M	Hold	119,888	–	–	0.01%	337
2015 Q4	$3.04M	Hold	119,888	–	–	0.01%	297
2015 Q3	$3.36M	Buy	119,888 +111,547	+1,337%	+$3.52M	0.01%	279
2015 Q2	$274K	Buy	+8,341	New	+$324K	﹤0.01%	417
2013 Q4	–	Sell	-729	Closed	-$607K	–	679
2013 Q3	$607K	Buy	729 +117	+19%	+$93.2K	﹤0.01%	522
2013 Q2	$487K	Buy	+612	New	+$495K	﹤0.01%	538

Other funds holding GYRO

TowerView LLC New York $155M AUM 30.14% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

RHAM

Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

JCP

Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBPWM

Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s GYRO Position: Q2 2024 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Gyrodyne (GYRO) in Q2 2024, closing a stake of 79,658 shares — an estimated $643K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GYRO in Q2 2013 and held it in 38 quarters. The position peaked at $3.36M in Q3 2015. 10 funds tracked by Wall St. Rank hold GYRO as of Q2 2024.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Gyrodyne position as of Q2 2024 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 79,658 Gyrodyne shares in Q2 2024, an estimated $643K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Gyrodyne in Q2 2013 and held it in 38 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Gyrodyne position peaked at $3.36M in Q3 2015.
10 funds tracked by Wall St. Rank held Gyrodyne as of Q2 2024.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2024, filed 13 Aug 2024.